Clinical Trial Update: Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating temozolomide with ZARNESTRA (R115777) in recurrent and progressive glioblastoma multiforme completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Temozolomide (Temozolomide)
• ZARNESTRA

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-09-16